The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function.

@article{Pitt2001TheQI,
  title={The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function.},
  author={Bertram C Pitt and Blair O'Neill and Robert Feldman and Roberto Ferrari and Leonard Schwartz and Harald G Mudra and Theodore Bass and Carl Pepine and Michele Texter and Hans-P. Haber and Andrew CG Uprichard and Linda Cashin-Hemphill and Robert S. Lees},
  journal={The American journal of cardiology},
  year={2001},
  volume={87 9},
  pages={1058-63}
}
Angiotensin-converting enzyme inhibitors improve endothelial function, inhibit experimental atherogenesis, and decrease ischemic events. The Quinapril Ischemic Event Trial was designed to test the hypothesis that quinapril 20 mg/day would reduce ischemic events (the occurrence of cardiac death, resuscitated cardiac arrest, nonfatal myocardial infarction, coronary artery bypass grafting, coronary angioplasty, or hospitalization for angina pectoris) and the angiographic progression of coronary… CONTINUE READING
57 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 57 extracted citations

Similar Papers

Loading similar papers…